CHEST Impact Factor 2022ChestnetThe ChestCHEST Journal indexingPulmonary articlesChest open accessCHEST journal 2022Chest Radiology JournalPulmonary articles
po文清單文章推薦指數： 80 %
關於「Pulmonary articles」標籤，搜尋引擎有相關的訊息討論：
Update on guidelines for the treatment of COPD in Taiwan using ...www.sciencedirect.com › science › article › piiDiagnostic differentiation between asthma and COPD in primary ...www.nature.com › ... › articlesEffect of 12-week pulmonary rehabilitation on cognitive function in ...www.ncbi.nlm.nih.gov › pmc › articles › PMC7569932The Diabetic Lung - A New Target Organ? - PMC - NCBIwww.ncbi.nlm.nih.gov › pmc › articles › PMC3448171One-year pulmonary impairment after severe COVID-19respiratory-research.biomedcentral.com › articlesChronic obstructive pulmonary disease, lung function and risk of ...bmcpulmmed.biomedcentral.com › articlesLUNG Year in Review: 2021 | SpringerLinklink.springer.com › articleUpdate in Chronic Obstructive Pulmonary Disease 2020www.atsjournals.org › doiThe Clinical Respiratory Journal - Wiley Online Libraryonlinelibrary.wiley.com › journalJournal of Pulmonology and Respiratory Research | HSPIwww.pulmonolrespirjournal.com
延伸文章資訊
- 1PK/PD and Long Term Safety Study of Benralizumab in ...
To evaluate the pharmacokinetics (PK) of Benralizumab administered subcutaneously (SC) in childre...
- 2Fasenra, INN-benralizumab - European Medicines Agency |
*Benralizumab is a humanised monoclonal antibody produced in Chinese hamster ovary (CHO) cells by...
- 3Severe Eosinophilic Asthma Treatment | FASENRA ...
Do not use FASENRA if you are allergic to benralizumab or any of the ingredients in FASENRA. Do n...
- 4健保署公告：暫予支付含benralizumab成分藥品Fasenra注射劑 ...
Mepolizumab (如Nucala)、Benralizumab (如Fasenra)：（107/11/1、109/3/1） 1.限用於經胸腔內科或過敏免疫專科醫師診斷為嗜伊紅性(嗜酸性)白...
- 5Benralizumab - Wikipedia
Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is dev...
